polyinosinic polycytidylic acid poly ic (InvivoGen)

InvivoGen is a verified supplier

InvivoGen manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

InvivoGen polyinosinic polycytidylic acid poly ic
Polyinosinic Polycytidylic Acid Poly Ic, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 856 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/poly+ic/Poly/10__3390_slash_biomedicines14061329-68-55-64
Average 99 stars, based on 856 article reviews

polyinosinic polycytidylic acid poly ic - by Bioz Stars, 2026-10

99/100 stars

Images

In Vitro:

Article Title: Nanostructured lipid carriers and stable emulsions and uses thereof
Article Snippet: TABLE 7 Z-average [nm] (PDI) at date of Name Description manufacturing QG942 Nanostructured Lipid Carrier 40.55 (0.198) QG843 Cationic nanoemulsion (CNE) manufactured according to Brito et al 95.04 (0.092) QH007 4 mgCa/ml hydroxyapatite nanoparticles (Sigma-Aldrich catalog# 900194) 101.3 (0.164) stabilized with 2 mg/ml chitosan (Sigma catalog# 448877) QH005 4 mgCa/ml hydroxyapatite nanoparticles (Sigma-Aldrich catalog# 900194) 91.8 (0.177) stabilized with 2 mg/ml chitosan (Polysciences catalog# 21161) QH006 4 mgCa/ml hydroxyapatite nanoparticles (Sigma-Aldrich catalog# 900194) 77.93 (0.184) stabilized with 2 mg/ml chitosan (Sigma catalog# 448869) QH008 4 mgCa/ml hydroxyapatite nanoparticles (Sigma-Aldrich catalog# 900194) 93.69 (0.186) stabilized with 2 mg/ml chitosan (Sigma catalog# 419419) QH009 2 mgAl/ml Alhydrogel treated with phosphate buffer, then stabilized with 1 294.1 (0.217) mg/ml chitosan (Polysciences catalog# 21161) QH142 2 mgAl/ml Alhydrogel treated with phosphate buffer, then stabilized with 1 304.8 (0.291) mg/ml chitosan (Sigma catalog# 419419) QH141 2 mgAl/ml Alhydrogel treated with phosphate buffer, then stabilized with 1 318.3 (0.288) mg/ml chitosan (Sigma catalog# 448877) QH140 2 mgAl/ml Alhydrogel treated with phosphate buffer, then stabilized with 1 347.4 (0.307) mg/ml chitosan (Sigma catalog# 448869) QH115 9 mgAl/ml Alhydrogel stabilized with 7.5 mg/ml polyacrylic acid 72.2 (0.200) (Polysciences catalog# 06519) QH011 9 mgAl/ml Alhydrogel stabilized with 30 mg/ml polyacrylic acid (Sigma 77.28 (0.144) catalog# 535931) Double-stranded RNA (dsRNA) adjuvants are enhanced by formulating with NLCs (WG942). .. Replicon RNA (ssRNA) encoding SEAP was co-formulated with dsRNA (dsRNA tested included Toil-like receptor 3 (TLR3) ligands such as Poly(IC) (synthetic 1.5-1.8 kb analog of dsRNA from Invivogen), Riboxxol (50 bp synthetic dsRNA from Riboxx, SEVDI (in vitro transcribed approximately 550 bp sendai virus defecting interfering RNA) or media control to evaluate the effect of adjuvant stimulation on protein expression (FIGS. 35A-E and 36A-D). .. Replicon RNA (ssRNA) encoding SEAP was co-formulated with dsRNA (dsRNA tested included Toil-like receptor 3 (TLR3) ligands such as Poly(IC) (synthetic 1.5-1.8 kb analog of dsRNA from Invivogen), Riboxxol (50 bp synthetic dsRNA from Riboxx, SEVDI (in vitro transcribed approximately 550 bp sendai virus defecting interfering RNA) or media control to evaluate the effect of adjuvant stimulation on protein expression (FIGS. 35A-E and 36A-D).

Virus:

Control:

Article Title: Ontogeny and functional potential of founding dendritic cells in the developing lung
Article Snippet: Each well contained 90ul of culture media constituted of DMEM (GIBCO), 10% Fetal Calf bovine serum (GIBCO), 1% L-glutamine (GIBCO), 1% sodium pyruvate (GIBCO), 1% MEM-NEAA (GIBCO), 1% Pencillin-Steptomycin (GIBCO), 55uM 2-mecaptaethanol. .. At the time of culturing, treatment groups received either 250ng/ml Poly IC (Invivogen) or 50ng/ml Pam3CSK (Invivogen) and the control received PBS. .. At 24 Hr time point the plate was spun down at 5000 RPM for 6 min at 4C and the supernatant was collected into 0.65 ml snap cap tubes, stored in - 20 C. Collected samples were tested for cytokines by Eve technologies corporation (Calgary, Canada) using Mouse Cytokine/Chemokine 44-Plex Discovery Assay® Array (MD44).

Adjuvant:

Expressing:

Sterility:

Article Title: Ontogeny and functional potential of founding dendritic cells in the developing lung
Article Snippet: .. Newborn mice were administered with sterile 1xPBS, 10mg/kg Poly IC (Inviovogen, Poly(I:C) LMW, tlrl-picw) or 10mg/kg Pam3CSK4 (Invivogen, Pam3CSK4:Synthetic triacylated lipopeptide; TLR2/TLR1 agonist, tlrl-pms) in total of 20ul volume intraperitoneally using a Hamilton Syringe (Model 705 RN SYR) and a 34 gauge needle (Hamilton, Small Hub RN Needle, custom length-0.5 inch, point style 4, 12 grade). .. DCs were sorted and cultured in TC treated 384-well plate (Thermofisher) at 3000 Cells per well.

other:

Article Title: Anti-SARS-CoV-2 Small Molecule Targeting of Oxysterol-Binding Protein (OSBP) Activates Cellular Antiviral Innate Immunity
Article Snippet: The next day the media was replaced with 1 mL of fresh BLEAM (untreated) or BLEAM supplemented with differing concentrations (0.1, 1, or 10 μg/mL) of poly IC (catalog number tlrl-pic, InvivoGen, San Diego, CA, USA), and harvested for analysis at 6 and 24 h post-treatment.

Article Title: VSV ∆M51 drives CD8 + T cell-mediated tumour regression through infection of both cancer and non-cancer cells
Article Snippet: The next day, media on MuTuDCs was removed and replaced with either 200 μL of complete media, mIFNβ (2 ng/mL), poly:IC (1:1000, InvivoGen, tlrl-pic), control mouse serum (diluted to 25% in complete IMDM media), or VSV ∆M51 conditioned mouse serum (diluted to 25% in complete IMDM media).

Review